Biofrontera Inc. — Regulatory Filings 2021

Dec 21, 2021

CORRESP 1 filename1.htm

Biofrontera Inc

120 Presidential Way, Suite 330

Woburn, MA 01801 USA

VIA EDGAR

December 21, 2021

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Re: Biofrontera Inc. Registration Statement on Form S-1 (File No. 333-261812) Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Biofrontera Inc. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended, the “ Registration Statement ”) so that the Registration Statement will be declared effective as of 5:00 p.m. Eastern time, on December 23, 2021, or as soon thereafter as practicable. The Registrant hereby also authorizes Stephen Older and Andrew Terjesen of McGuireWoods LLP to orally modify or withdraw this request for acceleration.

Once the Registration Statement has been declared effective, please orally confirm that event with Stephen Older of McGuireWoods LLP at (212) 548-2122, or in his absence, Andrew Terjesen at (704) 343-2024.

Thank you for your assistance in this matter.

| Very
truly yours, | |
| --- | --- |
| Biofrontera
Inc. | |
| /s/
Erica Monaco | |
| Name: | Erica
Monaco |
| Title: | Chief
Executive Officer |

cc:
Biofrontera
Inc.
Stephen
Older
McGuireWoods
LLP

| Biofrontera
Inc. 120 Presidential Way, Suite 330 Woburn, MA 01801 USA |
| --- |
| Contact
Phone +1 781 245 1325 Email info-us@biofrontera.com www.biofrontera-us.com |

Field: Page; Sequence: 1; Options: Last

Page 1 of 1

Field: /Page